Clinical Trial Update: Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma

View source ↗

Summary

A completed clinical trial investigating a single-cell regulons atlas for pancreatic ductal adenocarcinoma to support a molecular prognostic model.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Tiejun Ying | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Molecular Prognostic Model | Status: COMPLETED